{"count": 9, "results": [{"_id": "32557328", "pmid": 32557328, "title": "Differential effects of metformin on reductive activity and energy production in pituitary tumor cells compared to myogenic precursors.", "journal": "Endocrine", "authors": ["Tulipano G", "Paghera S", "Missale C", "Giustina A"], "date": "2020-09-01T00:00:00Z", "doi": "10.1007/s12020-020-02373-7", "meta_date_publication": "2020 Sep", "meta_volume": "69", "meta_issue": "3", "meta_pages": "604-614", "score": 50263.29, "text_hl": "Differential effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on reductive activity and energy production in @<m>DISEASE_Pituitary_Neoplasms</m> @DISEASE_MESH:D010911 @@@pituitary tumor@@@ cells compared to myogenic precursors.", "citations": {"NLM": "Tulipano G, Paghera S, Missale C, Giustina A. Differential effects of metformin on reductive activity and energy production in pituitary tumor cells compared to myogenic precursors. Endocrine. 2020 Sep;69(3):604-614. PMID: 32557328", "BibTeX": "@article{32557328, title={Differential effects of metformin on reductive activity and energy production in pituitary tumor cells compared to myogenic precursors.}, author={Tulipano G and Paghera S and Missale C and Giustina A}, journal={Endocrine}, volume={69}, number={3}, pages={604-614}}"}}, {"_id": "34311387", "pmid": 34311387, "title": "Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers.", "journal": "Curr Opin Pharmacol", "authors": ["León-González AJ", "Jiménez-Vacas JM", "Fuentes-Fayos AC", "Sarmento-Cabral A", "Herrera-Martínez AD", "Gahete MD", "Luque RM"], "date": "2021-10-01T00:00:00Z", "doi": "10.1016/j.coph.2021.06.002", "meta_date_publication": "2021 Oct", "meta_volume": "60", "meta_issue": "", "meta_pages": "17-26", "score": 50253.918, "text_hl": "@GENE_INS @GENE_3630 @@@insulin@@@ and its analogs, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, statins, etc.) in @DISEASE_Endocrine_Gland_Neoplasms @DISEASE_MESH:D004701 @@@endocrine-related cancers@@@ including @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@breast cancer@@@, @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@prostate cancer@@@, @<m>DISEASE_Pituitary_Neoplasms</m> @DISEASE_MESH:D010911 @@@pituitary cancer@@@, @DISEASE_Ovarian_Neoplasms @DISEASE_MESH:D010051 @@@ovarian cancer@@@, and @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@neuroendocrine neoplasms@@@. ", "citations": {"NLM": "León-González AJ, Jiménez-Vacas JM, Fuentes-Fayos AC, Sarmento-Cabral A, Herrera-Martínez AD, Gahete MD, Luque RM. Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers. Curr Opin Pharmacol. 2021 Oct;60():17-26. PMID: 34311387", "BibTeX": "@article{34311387, title={Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers.}, author={León-González AJ and Jiménez-Vacas JM and Fuentes-Fayos AC and Sarmento-Cabral A and Herrera-Martínez AD and Gahete MD and Luque RM}, journal={Curr Opin Pharmacol}, volume={60}, pages={17-26}}"}}, {"_id": "38147953", "pmid": 38147953, "title": "Metformin inhibits cell proliferation and ACTH secretion in AtT20 cells via regulating the MAPK pathway.", "journal": "Mol Cell Endocrinol", "authors": ["Sun Y", "Cheng J", "Nie D", "Fang Q", "Li C", "Zhang Y"], "date": "2023-12-24T00:00:00Z", "doi": "10.1016/j.mce.2023.112140", "meta_date_publication": "2023 Dec 24", "meta_volume": "582", "meta_issue": "", "meta_pages": "112140", "score": 50252.797, "text_hl": "The @SPECIES_10090 @@@mouse@@@ @<m>DISEASE_Pituitary_Neoplasms</m> @DISEASE_MESH:D010911 @@@pituitary tumor@@@ @CELLLINE_CVCL:2300 @@@AtT20@@@ cell line was treated with varying concentrations of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Sun Y, Cheng J, Nie D, Fang Q, Li C, Zhang Y. Metformin inhibits cell proliferation and ACTH secretion in AtT20 cells via regulating the MAPK pathway. Mol Cell Endocrinol. 2023 Dec 24;582():112140. PMID: 38147953", "BibTeX": "@article{38147953, title={Metformin inhibits cell proliferation and ACTH secretion in AtT20 cells via regulating the MAPK pathway.}, author={Sun Y and Cheng J and Nie D and Fang Q and Li C and Zhang Y}, journal={Mol Cell Endocrinol}, volume={582}, pages={112140}}"}}, {"_id": "33477154", "pmid": 33477154, "title": "Prolactin Response to Metformin in Cabergoline-Resistant Prolactinomas: A Pilot Study.", "journal": "Neuroendocrinology", "authors": ["Portari LHC", "Correa-Silva SR", "Abucham J"], "date": "2022-01-01T00:00:00Z", "doi": "10.1159/000514591", "meta_date_publication": "2022", "meta_volume": "112", "meta_issue": "1", "meta_pages": "68-73", "score": 50252.53, "text_hl": "However, 10-20% of @DISEASE_Prolactinoma @DISEASE_MESH:D015175 @@@prolactinomas@@@ are resistant to @CHEMICAL_Cabergoline @CHEMICAL_MESH:D000077465 @@@cabergoline@@@. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, a @CHEMICAL_Biguanides @CHEMICAL_MESH:D001645 @@@biguanide@@@ widely used in the treatment of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@, has been shown to reduce @GENE_PRL @GENE_5617 @@@prolactin@@@ secretion in various @<m>DISEASE_Pituitary_Neoplasms</m> @DISEASE_MESH:D010911 @@@pituitary tumor@@@-cell lineages both in vitro and in vivo and in @SPECIES_9606 @@@human@@@ @<m>DISEASE_Pituitary_Neoplasms</m> @DISEASE_MESH:D010911 @@@pituitary adenomas@@@ in vitro. ", "citations": {"NLM": "Portari LHC, Correa-Silva SR, Abucham J. Prolactin Response to Metformin in Cabergoline-Resistant Prolactinomas: A Pilot Study. Neuroendocrinology. 2022;112(1):68-73. PMID: 33477154", "BibTeX": "@article{33477154, title={Prolactin Response to Metformin in Cabergoline-Resistant Prolactinomas: A Pilot Study.}, author={Portari LHC and Correa-Silva SR and Abucham J}, journal={Neuroendocrinology}, volume={112}, number={1}, pages={68-73}}"}}, {"_id": "38379171", "pmid": 38379171, "title": "The Effect of Metformin Treatment on Disease Control in Patients with Acromegaly.", "journal": "Endocr Metab Immune Disord Drug Targets", "authors": ["Sahin HR", "Sahin S", "Sarac B", "Sulu C", "Kadioglu P", "Ozkaya HM"], "date": "2024-01-01T00:00:00Z", "doi": "10.2174/0118715303260084231102105149", "meta_date_publication": "2024", "meta_volume": "24", "meta_issue": "6", "meta_pages": "709-716", "score": 50251.094, "text_hl": "OBJECTIVE: We evaluated the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment in @SPECIES_9606 @@@patients@@@ with @DISEASE_Acromegaly @DISEASE_MESH:D000172 @@@acromegaly@@@ on @GENE_GH1 @GENE_2688 @@@growth hormone@@@, insulin-like growth hormone-1, and @<m>DISEASE_Pituitary_Neoplasms</m> @DISEASE_MESH:D010911 @@@pituitary adenoma@@@ size. ", "citations": {"NLM": "Sahin HR, Sahin S, Sarac B, Sulu C, Kadioglu P, Ozkaya HM. The Effect of Metformin Treatment on Disease Control in Patients with Acromegaly. Endocr Metab Immune Disord Drug Targets. 2024;24(6):709-716. PMID: 38379171", "BibTeX": "@article{38379171, title={The Effect of Metformin Treatment on Disease Control in Patients with Acromegaly.}, author={Sahin HR and Sahin S and Sarac B and Sulu C and Kadioglu P and Ozkaya HM}, journal={Endocr Metab Immune Disord Drug Targets}, volume={24}, number={6}, pages={709-716}}"}}, {"_id": "28380462", "pmid": 28380462, "pmcid": "PMC5514928", "title": "Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells", "journal": "Oncotarget", "authors": ["An J", "Pei X", "Zang Z", "Zhou Z", "Hu J", "Zheng X", "Zhang Y", "He J", "Duan L", "Shen R", "Zhang W", "Zhu F", "Li S", "Yang H"], "date": "2017-06-06T00:00:00Z", "doi": "10.18632/oncotarget.16556", "meta_date_publication": "2017 Jun 6", "meta_volume": "8", "meta_issue": "23", "meta_pages": "37538-37549", "score": 50062.375, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits proliferation and @GENE_GH1 @GENE_2688 @@@growth hormone@@@ secretion of @CELLLINE_CVCL:0273 @@@GH3@@@ @<m>DISEASE_Pituitary_Neoplasms</m> @DISEASE_MESH:D010911 @@@pituitary adenoma@@@ cells", "citations": {"NLM": "An J, Pei X, Zang Z, Zhou Z, Hu J, Zheng X, Zhang Y, He J, Duan L, Shen R, Zhang W, Zhu F, Li S, Yang H. Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells Oncotarget. 2017 Jun 6;8(23):37538-37549. PMID: 28380462", "BibTeX": "@article{28380462, title={Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells}, author={An J and Pei X and Zang Z and Zhou Z and Hu J and Zheng X and Zhang Y and He J and Duan L and Shen R and Zhang W and Zhu F and Li S and Yang H}, journal={Oncotarget}, volume={8}, number={23}, pages={37538-37549}}"}}, {"_id": "30025915", "pmid": 30025915, "title": "Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells.", "journal": "Mol Cell Endocrinol", "authors": ["Jin K", "Ruan L", "Pu J", "Zhong A", "Wang F", "Tan S", "Huang H", "Mu J", "Yang G"], "date": "2018-12-15T00:00:00Z", "doi": "10.1016/j.mce.2018.07.007", "meta_date_publication": "2018 Dec 15", "meta_volume": "478", "meta_issue": "", "meta_pages": "53-61", "score": 50057.12, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ may have direct antitumor activity against @<m>DISEASE_Pituitary_Neoplasms</m> @DISEASE_MESH:D010911 @@@pituitary corticotroph tumors@@@.", "citations": {"NLM": "Jin K, Ruan L, Pu J, Zhong A, Wang F, Tan S, Huang H, Mu J, Yang G. Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells. Mol Cell Endocrinol. 2018 Dec 15;478():53-61. PMID: 30025915", "BibTeX": "@article{30025915, title={Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells.}, author={Jin K and Ruan L and Pu J and Zhong A and Wang F and Tan S and Huang H and Mu J and Yang G}, journal={Mol Cell Endocrinol}, volume={478}, pages={53-61}}"}}, {"_id": "28962892", "pmid": 28962892, "title": "Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals.", "journal": "Mol Cell Endocrinol", "authors": ["Faggi L", "Giustina A", "Tulipano G"], "date": "2018-07-15T00:00:00Z", "doi": "10.1016/j.mce.2017.09.030", "meta_date_publication": "2018 Jul 15", "meta_volume": "470", "meta_issue": "", "meta_pages": "60-74", "score": 50056.85, "text_hl": "Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on cell growth and @GENE_PRKAA2 @GENE_78975 @@@AMPK@@@ activity in @<m>DISEASE_Pituitary_Neoplasms</m> @DISEASE_MESH:D010911 @@@pituitary adenoma@@@ cell cultures, focusing on the interaction with adenylyl cyclase activating signals.", "citations": {"NLM": "Faggi L, Giustina A, Tulipano G. Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals. Mol Cell Endocrinol. 2018 Jul 15;470():60-74. PMID: 28962892", "BibTeX": "@article{28962892, title={Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals.}, author={Faggi L and Giustina A and Tulipano G}, journal={Mol Cell Endocrinol}, volume={470}, pages={60-74}}"}}, {"_id": "23729615", "pmid": 23729615, "title": "Pituitary gigantism presenting with depressive mood disorder and diabetic ketoacidosis in an Asian adolescent.", "journal": "J Pediatr Endocrinol Metab", "authors": ["Kuo SF", "Chuang WY", "Ng S", "Chen CH", "Chang CN", "Chou CH", "Weng WC", "Yeh CH", "Lin JD"], "date": "2013-01-01T00:00:00Z", "doi": "10.1515/jpem-2013-0136", "meta_date_publication": "2013", "meta_volume": "26", "meta_issue": "9-10", "meta_pages": "945-8", "score": 50035.945, "text_hl": "He was then administered @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, 500 mg twice daily, and to date, his serum glycohemoglobin has been <7%.", "citations": {"NLM": "Kuo SF, Chuang WY, Ng S, Chen CH, Chang CN, Chou CH, Weng WC, Yeh CH, Lin JD. Pituitary gigantism presenting with depressive mood disorder and diabetic ketoacidosis in an Asian adolescent. J Pediatr Endocrinol Metab. 2013;26(9-10):945-8. PMID: 23729615", "BibTeX": "@article{23729615, title={Pituitary gigantism presenting with depressive mood disorder and diabetic ketoacidosis in an Asian adolescent.}, author={Kuo SF and Chuang WY and Ng S and Chen CH and Chang CN and Chou CH and Weng WC and Yeh CH and Lin JD}, journal={J Pediatr Endocrinol Metab}, volume={26}, number={9-10}, pages={945-8}}"}}]}